scholarly article | Q13442814 |
P50 | author | Chengwen Teng | Q59543001 |
P2093 | author name string | Christopher R Frei | |
John Hakim | |||
Kirk E Evoy | |||
Brian Frescas | |||
Stephen Saklad | |||
Victor G Encarnacion | |||
P2860 | cites work | Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports | Q34112790 |
Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN) | Q35647935 | ||
Quetiapine: treatment for substance abuse and drug of abuse | Q37116604 | ||
Quantitative signal detection using spontaneous ADR reporting | Q37439662 | ||
Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics. | Q37638936 | ||
A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile. | Q39434182 | ||
Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression. | Q42944127 | ||
Evaluation of quetiapine abuse and misuse reported to poison centers | Q45002147 | ||
Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database | Q47359368 | ||
A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics | Q48474995 | ||
Increasing rates of quetiapine overdose, misuse, and mortality in Victoria, Australia | Q88358600 | ||
The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance | Q88918943 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | quetiapine | Q408535 |
aripiprazole | Q411188 | ||
FDA Adverse Event Reporting System | Q4686710 | ||
Prescription Drug Abuse | Q59597078 | ||
P304 | page(s) | 1178221819844205 | |
P577 | publication date | 2019-05-01 | |
P1433 | published in | Substance Abuse: Research and Treatment | Q15766459 |
P1476 | title | Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics | |
P478 | volume | 13 |
Q89804908 | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database | cites work | P2860 |
Search more.